0000899243-22-030285.txt : 20220902 0000899243-22-030285.hdr.sgml : 20220902 20220902161512 ACCESSION NUMBER: 0000899243-22-030285 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220901 FILED AS OF DATE: 20220902 DATE AS OF CHANGE: 20220902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kennedy Eugene P. CENTRAL INDEX KEY: 0001721685 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 221225287 MAIL ADDRESS: STREET 1: 2503 SOUTH LOOP DRIVE CITY: AMES STATE: IA ZIP: 50010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-01 0 0001563577 Galera Therapeutics, Inc. GRTX 0001721685 Kennedy Eugene P. C/O GALERA THERAPEUTICS, INC., 2 W LIBERTY BLVD #100 MALVERN PA 19355 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 1.29 2022-09-01 4 A 0 150000 0.00 A 2032-08-31 Common Stock 150000 150000 D The option vests and becomes exercisable as to 25% on September 1, 2023, and in thirty-six (36) substantially equal monthly installments over a three-year period thereafter. /s/ Christopher Degnan, Attorney-in-Fact for Eugene P. Kennedy 2022-09-02